Viberzi and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Viberzi (eluxadoline), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Irritable bowel syndrome.

The phase IV clinical study analyzes which people have Dizziness when taking Viberzi. It is created by eHealthMe based on reports of 3,052 people who have side effects when taking Viberzi from the FDA, and is updated regularly.

What is Viberzi?

Viberzi has active ingredients of eluxadoline. eHealthMe is studying from 3,077 Viberzi users. Check the latest studies of Viberzi.

What is Dizziness?

Dizziness is found to be associated with 3,569 drugs and 5,712 conditions by eHealthMe. Check the latest studies of Dizziness.

On Aug, 01, 2026

3,052 people reported to have side effects when taking Viberzi.
Among them, 131 people (4.29%) have Dizziness.

Among these 131 people:

* Approximation only. Some reports may have incomplete information.

Do you take Viberzi and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viberzi:

Viberzi (3,077 reports)

Dizziness treatments and more:

Dizziness (613,962 reports)

How severe was Dizziness and when was it recovered:

Dizziness in Viberzi

Expand to all the drugs that have ingredients of eluxadoline:

Dizziness and drugs with ingredients of eluxadoline (132 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Viberzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,569 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,712 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eluxadoline (the active ingredients of Viberzi) and Viberzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.